Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise
about
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaDissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9The influence of Cox-2 and bioactive lipids on hematological cancers.Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motifGlobal gene expression profiling of a population exposed to a range of benzene levels.Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia.Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma.Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study.Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells.Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents.Structure-activity relationship study of novel anticancer aspirin-based compounds.Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas.COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).Regression of diffuse large B-cell lymphoma in sphenoid and ethmoid sinuses following treatment with loxoprofen.Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.
P2860
Q21135231-F8DC7119-4C7B-417D-BAF8-D48DF5D26EEAQ33495581-09FA8D6A-C907-4635-A151-1E518BDBB9D9Q33688673-7BEABC3A-8A14-49BF-BD88-A36592939A0AQ33846983-CD727567-A4A1-4B63-AFBD-25EF3CAB2494Q34980955-CB5531CB-49CF-4DFB-A209-E036DFDA5925Q35091515-07C7107F-08E0-465B-A10F-F77DCED9E0C8Q35156722-A2FE9F7F-4709-46A3-8DEB-F392D7FE210BQ36099292-EFD71B54-CA79-4C28-BB80-AA4A691AD93FQ36310570-BADD9C35-9195-4FB7-91C0-5F07091055A0Q37507892-08DF4FB7-C80C-4F27-99CE-624C2F977654Q39176686-EF02DF1C-6EA6-4EC5-8C06-D988207D5732Q39186804-9E8E244E-6CF9-4A5C-A736-3AA66FA9CB29Q39189510-AEFDD77A-D8DF-4A15-B91F-F4570A6CEBF1Q39497398-2813BC19-6A69-48F4-B74A-2B8A6A9B01CBQ41270773-7F42211E-65C9-4CB0-BF59-64964581F020Q53299556-6821CDB0-8F61-4149-A5B5-24451C6EB560Q53438099-2EF404D2-002C-4B6D-9F9A-41D8C3714683Q55503143-04826570-9257-42A6-8EDE-72C1A1BBA1EE
P2860
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise
@en
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
@nl
type
label
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise
@en
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
@nl
prefLabel
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise
@en
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
@nl
P2093
P2860
P1476
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise
@en
P2093
P2860
P304
P356
10.2174/138161208785294654
P577
2008-01-01T00:00:00Z